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INTRODUCTION
Burn pa ents undergo frequent extensive burn deb-
ridement and painful dressing changes. During these
procedures the pa ent requires anesthe c agents to
provide necessary deep seda on, along with analgesia.
Along with the anesthe c agents Opioids and Benzodi-
azepines are the most commonly used group of drugs.
Frequent use of Opioids and Benzodiazepines leads to
tolerance to the analgesia and seda on [1,2]. Tolerance
to Opioids and Benzodiazepines leads to increase in
doses in order to maintain adequate seda on and anal-
gesia during the procedure. The most common prob-
lems associated with significant burns (>20% total body
surface area) are prolonged recovery with high Opioid
and benzodiazepine a er each dressing change and
heterotopic ossifica on as a result of pain-limited mo-
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bility [3].
Ketamine and Propofol are the most common anes-
the c used along with Opioids and Benzodiazepines in
burns dressings. The addi on of these anesthe cs to a
regimen of Opioids and Benzodiazepines for dressing
not only decreases the Opioid and benzodiazepine re-
quirements but also facilitate improved compliance
with physical and occupa onal therapy leading to a
decreased incidence of heterotopic ossifica on [4].
Ketamine has been a safe and effec ve anesthe c
agent for burns dressings with a few limita ons such as
delayed recovery, emergence phenomenon, and nau-
sea and vomi ng [5].
Propofol have favorable pharmacokine cs but it lacks
the analgesic property intrinsic to Ketamine [6]. Fenta-
nyl is added to Propofol to compliment the analgesic
property. Recently Dexmedetomidine (Dex), a highly
selec ve α2-adrenoreceptor agonist, is used for seda-
on in various clinical se ngs and shows an anesthe c-
sparing effect [7-11]. Studies have shown that concomi-
tant Dexmedetomidine use may reduce the require-
ment of Propofol and Ketamine, with faster postopera-
ve recovery and more stable intraopera ve haemody-
namics [12].
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Hence, it was thought prudent to evaluate the changes
with use of   Dex in terms of requirement for Propofol,
Ketamine and intraopera ve haemodynamics during
burns debridement and dressing changes.
Aims and objec ves: To study the effects of Dexme-
detomidine as premedica on with Ketamine and
Propofol as sole anesthe c agents during burns deb-
ridement and dressing in terms of Changes in dose re-
quirements of Ketamine and Propofol, intraopera ve
haemodynamic, varia ons, recovery me.
MATERIALS AND METHODS
Study design: This was a longitudinal, prospective
study
Ethics approval: Approval from Institutional Ethical
Committee was dully taken and study was done after
ethical clearance.
Study location:done in depar tment of Anaesthesiolo-
gy and critical care at Pravara Rural Hospital, Loni
Study duration: Study was done over a period of 2
years.
Sample size: Total 60 Patients of scheduled for  elec-
tive burn debridement and dressings at P.R.H. Loni ad-
mitted in the wards were enrolled for the study during
the study period.
Patients satisfying the following eligibility criteria were
selected for the study.
Inclusion criteria: Patients scheduled for  the elective
burn debridement who received injection Propofol and
injection Ketamine with or without Dexmedetomidine.
Patients willing to give informed written consent. Pa-
tients of either sex. Patients of all age groups
Exclusion criteria: Pregnant, Lactating women. Pa-
tients with known allergy or contraindications to Dex-
med, Ketamine or Propofol. Patients with head injury.
Patients with history of Cardio-Respiratory disorders.
Hepatic, Renal diseases. Convulsions & neurological
deficits and psychiatric disorders.
Grouping: All the patients satisfying the above inclu-
sion and exclusion criteria were grouped as under de-
pending upon receipt of Dexmetomidine:
Group A (n=30): Patients received infusion of injection
Ketamine 1 mg/kg/hr and injection Propofol IV 100
mcg/kg/min.
Group B (n=30): Patients received  injection Dexme-
detomidine 1ug/kg I.M. as premedication 1 hour before
induction followed by infusion of  injection Propofol IV
100mcg/kg/min & injection Ketamine 1mg/kg/hr.
Both the groups were assessed to find out difference in
the dose requirement, haemodynamic variables such as
heart rate, blood pressure, immediately after LMA in-
sertion and at 5, 15, 30, 45, and 60 mins in both groups.
Recovery time for discontinuation of infusion and
achievement of RSS of 3 was noted. The analgesia and
sedation achieved were studied by using:
Ramsay sedation scale [13]:
If awake
1.Anxious, agitated, restless
2.Cooperative, oriented, tranquil
3.Responsive to commands only
If a sleep
4. Brisk response to light glabellar tap or loud audi-
tory stimulus
5. Sluggish response to light glabellar tap or loud
auditory stimulus4
6. No response to light glabellar tap or loud auditory
stimulus
RESULTS
Figure no.1: Age wise distribu on of the pa ents
The maximum number of pa ents were in between the
age of 31 to 40 years followed by 18 to 30 years
Figure no.2: Gender wise distribu on of pa ents
Shows highly significant number of female pa ents
79%
Figure no.3: Comparison of Heart Rate (beats per min)
at various me intervals
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Comparison of Heart Rate (beats/min) at various me
intervals heart rate was significantly higher in Group A
as compared to Group B. There was sta s cally signifi-
cant difference between the groups as per Student t-
test (p<0.05).
Figure no 5: Comparison of DBP (mmHg) at various
time intervals
Intraoperatively the diastolic blood pressure was signifi-
cantly higher in Group A as compared to Group B.
There was statistically significant difference between
the groups as per Student t-test (p<0.05)
Figure no.6: Comparison of mean recovery time
Figure no.4: Comparison of SBP (mm of Hg) at var-
ious time intervals
Intraoperatively the diastolic blood pressure was signif-
icantly higher in Group A as compared to Group B.
There was statistically significant difference between
the groups as per Student t-test (p<0.05)
Unpaired t test P value, the two-tailed P value is <
0.0001, considered extremely significant. t = 8.287 with
58 degrees of freedom. Inference: Less me was re-
quired by Group B for  recovery.
Figure no.7 : Comparison of changes in dose re-
quired of Ketamine
Unpaired t test P value, The two-tailed P value is <
0.0001, considered extremely Significant .t = 23.423
with 58 degrees of freedom, Inference: Lower dose of
Ketamine was required by Group B.
Figure no. 8: Comparison of changes in dose re-
quired of Profol
Unpaired t test P value, The two-tailed P value is <
0.0001, considered extremely significant. t = 24.566
with 58 degrees of freedom. Inference: Lower dose of
Propofol was required by Group B.
DISCUSSION
The present observa onal study was undertaken to
study the effects of Dexmedetomidine as premedica-
on with Ketamine and Propofol as sole anaesthe c
agents during burns debridement and dressing. The
pa ents were randomly divided into following two
groups with 30 subjects in each group:
Group A: All pa ents in this group received 20 ml NS
Intravenous over 10 min followed by Ketamine 1mg/kg
and Propofol 1mg/kg at induc on. Supplements of Ket-
amine 0.5mg/kg and Propofol 0.5 mg/kg were given as
and when required to maintain Ramsay Seda on Score
of 5 or more.
Group B: All pa ents in this group received Dexmedi-
tomidine 1mcg/kg in 20ml NS Intravenous over 10 min
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followed by Ketamine 1mg/kg and Propofol 1mg/kg at
induc on. Supplements of Ketamine 0.5mg/kg and
Propofol 0.5mg/kg were given as and when required to
maintain Ramsay Seda on Score of 5 or more.
In the present study, majority of the pa ents (40%) in
Group A were in the age group of 31-40 years and
(46.7%) in Group B were in the age group of 31-40
years No sta s cal difference was found by applying
Chi-Square test (p>0.05).(Figure no.1)
The gender distribu on in the two groups as per Fish-
er’s test were comparable and sta s cally not signifi-
cant (p>0.05). 40 % and 39% pa ents were females in
Group A and B respec vely (Figure no.2)Ravipa  P et al
[13] observed there was no sta s cally significant
difference in the demographic and clinical characteris-
cs among the two groups.
It was observed that intraopera vely the heart rate,
systolic and diastolic Blood pressure was significantly
higher in Group A as compared to Group B. There was
sta s cally significant difference between the groups
as per Student t-test (p<0.05). (Figure no.3, 4, and 5).
The recovery me in Group A was 12.9 mins as com-
pared to 9.5 mins in Group B. There was sta s cally
significant difference between the groups as per Stu-
dent t-test (p<0.05).
Ravipa  P et al [13] observed Time to recovery was
9.57 ± 1.50 min in the Dex group which was significant-
ly lower than in the control group 11.53 ± 2.56 min (P =
0.0006). (Figure no.6)
It was observed that dose requirement of Ketamine
(228.8±21.9) and Propofol (263.2 ± 22.5) was signifi-
cantly more in Group A as compared to Group B
(101.1±20.3 and 120.8±22.4 respec vely). Sta s cally
significant difference was found by applying Student t-
test (p<0.05). (Figure no.7) Ravipa  P et al [13] ob-
served mean dose of Ketamine used in Dex group was
significantly less (100.5 ± 17.58 mg) whereas it was
231.5 ± 60.39 mg in the control group (P < 0.0001).
Similarly, mean dose of Propofol in Dex and control
groups were 127.7 ± 15.47 mg and 254 ± 59.22 mg re-
spec vely (P < 0.0001).
Dexmedetomidine, by ac va ng pre and postsynap c
α2-receptors of sympathe c system produces vasodila-
ta on. By ac ng on postsynap c α2-receptors of vascu-
lar smooth muscle cells it produces vasoconstric on. It
thereby, shows a biphasic, dose-dependent response
on blood pressure and heart rate, characterized by an
ini al short-term increase in BP followed by a longer
las ng reduc on in BP and HR [14-17] Most previous
inves ga ons have proven the cardiovascular depres-
sive effects of IM Dex at a dose of 2.5 μg/kg which in-
creases the incidence of hypotension and bradycardia
[18]. However, VirkkilaM et al [19] showed that IM Dex
1 μg/kg produced seda on and a reduc on of intraocu-
lar pressure with minimal haemodynamic side effects
when given as premedica on before cataract surgery
under regional anesthesia. According to An la Met al
[20] IM Dex provides complete bioavailability and
needs less preopera ve monitoring as compared to IV
Dex. Also, Scheinin H et al [21] showed that the intra-
muscular doses resulted in linearly dose-related plasma
concentra ons of Dexmedetomidine; henceforth, clear-
ance and half-life remains constant irrespec ve of its
plasma concentra on. For all these reasons we evaluat-
ed the effect of 1.0 μg/kg IM Dex on the requirement
for supplemental Propofol and Ketamine during anes-
thesia for burns debridement and dressing changes.
Despite the limited data, the advantage of adding Dex-
medetomidine with Ketamine is that both balance the
haemodynamic and adverse effects of each other. Dex-
medetomidine may decrease the incidence of tachycar-
dia, hypertension, saliva on, and emergence phenome-
na from Ketamine, while Ketamine may prevent the
bradycardia and hypotension of Dexmedetomidine.
Addi onally, Ketamine as part of the seda on induc on
may speed the onset of seda on and eliminate the
slow onset me of IM Dex [22].
CONCLUSION
Dexmedetomidine (1 μg/kg IM dose) is a good anes-
the c adjuvant that decreases the requirement of
Propofol and Ketamine during burns debridement and
dressings, a enuates sympathoadrenal response,
maintains stable intraopera ve haemodynamic and
also has an excellent recovery profile.
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